What's New on the FDA Drugs Site
June 14, 2016
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Safety Communication: FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR)
- La FDA advierte de problemas cardiacos graves con dosis altas del medicamento antidiarreico loperamida (Imodium), incluyendo por su consumo excesivo e indebido
- Manual of Policies and Procedures (MAPP) 6020.8 Rev. 1 NDAs/BLAs/Efficacy Supplements: Action Packages and Taking Regulatory Actions (PDF - 282KB)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario